Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 October 2006

Influence of 12-week exercise training on fat mass percentage in adolescents with Down syndrome

Fransisco J Ordonez, Manuel Rosety, Manuel Rosety-Rodriguez

Med Sci Monit 2006; 12(10): CR416-419 :: ID: 459195

Abstract

Background: Current fi ndings suggest that more attention needs to be given to the increase in body mass achieved by disabled populations, especially by individuals with mental retardation, to minimize long-term negative health consequences. Accordingly, it would be of interest to design adequate strategies
based on physical activities that may be easily performed to ensure adherence as a healthy lifestyle
choice for these populations.
Material/Methods: To attain this goal, 22 male adolescents with Down’s syndrome (mean age: 16.2±1.0 years) underwent a 12-week physical exercise intervention consisting of three sessions of one hour per week in both water and on land for 12 weeks. Fat mass percentage was calculated from anthropometric
measurements according to the Durnin-Womersley equation. A paired t test was performed to
evaluate possible differences in antropometrical characteristics between before and after the physical
exercise intervention.
Results: According to the body mass index, it was observed that 31.8% of the studied individuals presented overweight and 27.3% of them were obese before starting our experiment. The mean value of
the percentage of fat mass was reduced signifi cantly, from 31.8±3.7% to 26±2.3%, at the end of the
study (p=0.021).
Conclusions: We may conclude that the adolescents with Down’s syndrome were able to reduce their fat mass percentage signifi cantly when performing a 12-week training program, which could have important
impact on the comorbidity associated with obesity and on the quality of life of this population.

Keywords: Body Composition, Adolescent, Body Mass Index, Down Syndrome - metabolism, Exercise - physiology, Obesity - rehabilitation, Skinfold Thickness, Time Factors

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Database Analysis  

Long-Term Prognosis of Patients Undergoing Percutaneous Coronary Intervention: The Impact of Serum Creatini...

Med Sci Monit In Press; DOI: 10.12659/MSM.943063  

Database Analysis  

Maternal Exposure to Environmental Air Pollution and Premature Rupture of Membranes: Evidence from Southern...

Med Sci Monit In Press; DOI: 10.12659/MSM.943601  

Animal Research  

Enhanced Bone Healing Through Systemic Capsaicin Administration: An Experimental Study on Wistar Rats

Med Sci Monit In Press; DOI: 10.12659/MSM.942485  

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750